UPDATE: MKM Partners Reiterates On Auxilium Pharmaceuticals, Inc. As Endo Bid Is Likely Too Low

By: via Benzinga
In a report published Wednesday, MKM Partners analyst Jon LeCroy reiterated a Buy rating on Auxilium Pharmaceuticals, Inc. (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.